Baotou Tianhe Magnetics Technology
603072
HuangShan Googe
301581
Geovis Insighter Technology
920116
CHICHENG ELECTRIC
834407
Xdc Industries(Shenzhen)Limited
300615
CN Stock MarketDetailed Quotes
603707 Nanjing King-Friend Biochemical Pharmaceutical
- 12.26
- -0.71-5.47%
Market Closed Jan 3 15:00 CST
19.81BMarket Cap-46.79P/E (TTM)
12.98High11.97Low253.85KlotVolume12.98Open12.97Pre Close314.32MTurnover1.57%Turnover RatioLossP/E (Static)1.62BShares16.0152wk High3.18P/B19.81BFloat Cap10.4552wk Low14.27Limit Up1.62BShs Float35.10Historical High11.67Limit Down7.79%Amplitude2.15Historical Low0.10Dividend TTM12.38Avg Price105.14KlotAsk0.82%Div YieldTTM100Lot Size127.36KlotBid
Nanjing King-Friend Biochemical Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -1.72%3.09B | -6.99%2.14B | -23.19%1B | 5.89%3.93B | 10.20%3.14B | 16.63%2.3B | 11.13%1.31B | 0.71%3.71B | 2.55%2.85B | 12.79%1.98B |
| Operating revenue | -1.72%3.09B | -6.99%2.14B | -23.19%1B | 5.89%3.93B | 10.20%3.14B | 16.63%2.3B | 11.13%1.31B | 0.71%3.71B | 2.55%2.85B | 12.79%1.98B |
| Other operating revenue | ---- | -13.72%3.2M | ---- | 87.76%8.65M | ---- | -19.17%3.71M | ---- | -12.15%4.61M | ---- | 60.27%4.59M |
| Total operating cost | 11.24%2.43B | 8.47%1.71B | -12.57%806.72M | 15.57%2.95B | 19.95%2.18B | 23.89%1.58B | 17.06%922.71M | 1.34%2.55B | 1.23%1.82B | 14.41%1.27B |
| Operating cost | 13.80%1.81B | 10.66%1.28B | -4.23%617.68M | 14.75%2.03B | 17.24%1.59B | 23.52%1.16B | 10.73%644.98M | 10.77%1.77B | 13.46%1.36B | 25.78%936.87M |
| Operating tax surcharges | -49.28%16.66M | -58.99%9.35M | -71.28%3.93M | 79.90%55.73M | 37.45%32.85M | 24.03%22.79M | 51.79%13.7M | 39.83%30.98M | 243.90%23.9M | 618.11%18.38M |
| Operating expense | -37.26%193.7M | -45.42%142.75M | -46.06%65.19M | -6.89%420.57M | -11.93%308.72M | 21.40%261.56M | 18.61%120.85M | -6.63%451.72M | -4.95%350.53M | -5.47%215.45M |
| Administration expense | 15.18%121.23M | 24.63%86.15M | 21.08%39.41M | -12.05%145.9M | 2.27%105.25M | 7.00%69.12M | 4.04%32.55M | 35.72%165.89M | 45.85%102.91M | 44.07%64.6M |
| Financial expense | 212.02%72.87M | 118.86%16.16M | -86.99%5.59M | 42.25%-74.2M | 62.59%-65.05M | -23.86%-85.7M | 327.23%42.98M | -276.67%-128.5M | -4,307.00%-173.86M | -1,555.85%-69.19M |
| -Interest expense (Financial expense) | -7.13%59.83M | 6.27%42.65M | 4.48%20.16M | 40.10%81.05M | 40.39%64.43M | 42.79%40.13M | 48.29%19.3M | -37.27%57.85M | 33.88%45.89M | -46.75%28.11M |
| -Interest Income (Financial expense) | 48.78%-16.98M | 30.31%-11.69M | 53.99%-5.17M | 16.20%-27.98M | -111.47%-33.15M | -110.39%-16.78M | -280.31%-11.23M | -177.31%-33.39M | -371.93%-15.68M | 11.06%-7.98M |
| Research and development | 1.61%216.23M | 15.60%174.34M | 10.73%74.9M | 41.20%372.29M | 31.75%212.8M | 42.46%150.81M | 26.53%67.64M | 19.33%263.66M | 5.39%161.52M | 10.52%105.86M |
| Credit Impairment Loss | -519.32%-6.07M | -300.12%-8.59M | 57.44%-3.23M | 685.98%3.32M | -57.23%1.45M | -298.10%-2.15M | -116.64%-7.58M | 113.10%422.07K | 112.16%3.38M | 108.36%1.08M |
| Asset Impairment Loss | ---- | ---- | ---- | -12,070.59%-1.24B | ---- | ---- | ---- | -41.38%-10.22M | 99.96%-2.56K | 99.96%-2.56K |
| Other net revenue | 377.74%51.24M | 646.06%26.4M | 122.83%1.21M | -10,251.91%-1.28B | -179.98%-18.45M | -126.77%-4.83M | -1,942.69%-5.31M | -5.11%12.58M | 236.85%23.07M | 220.40%18.05M |
| Fair value change income | 245.38%4.97M | -324.15%-9.29M | ---4.21M | 40.47%-3.01M | 128.48%1.44M | 56.49%-2.19M | ---- | -155.64%-5.06M | -252.20%-5.06M | -182.95%-5.04M |
| Invest income | 90.89%-1.96M | 125.92%169.41K | -75.12%533.74K | -424.48%-88.73M | -187.18%-21.47M | -102.98%-653.6K | -38.71%2.15M | 76.59%27.35M | 75.95%24.63M | 254.37%21.9M |
| -Including: Investment income associates | ---- | ---- | ---- | ---- | -68.85%5.08M | -74.71%3.39M | 3,552.59%2.14M | 457.55%21.67M | 405.39%16.3M | 443.90%13.39M |
| Asset deal income | 28.38%-18.56K | -165.39%-13.17K | -4,181.09%-12.5K | 64.15%-41.17K | 74.75%-25.91K | 95.04%-4.96K | ---292 | 88.83%-114.84K | -68.74%-102.61K | -149.51%-100.08K |
| Other revenue | 33,140.02%54.32M | 26,903.89%44.13M | 6,250.12%8.13M | 27,447.57%54.91M | -22.54%163.4K | -20.58%163.4K | -38.44%128.03K | 21.81%199.33K | 28.91%210.95K | 25.74%205.75K |
| Adjusted Items effecting operating profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- |
| Operating profit | -24.47%709.24M | -36.42%459.76M | -47.62%198.76M | -125.11%-294.71M | -10.82%939.02M | 0.23%723.08M | -2.22%379.46M | -0.71%1.17B | 9.19%1.05B | 15.52%721.4M |
| Add:Non operating Income | ---- | ---- | -18.86%1.79M | -99.89%13.5K | 783.92%18.03M | 369.44%15.27M | 32.16%2.21M | -43.27%12.4M | -123.82%-2.64M | -139.74%-5.67M |
| Less:Non operating expense | 33,413.14%2.3M | 148,595.36%89.75K | 120,608.39%63.31K | -89.15%63.14K | -97.97%6.85K | -99.98%60.36 | --52.45 | 1,601.09%581.92K | 4,358.61%338K | 4,140.49%313.4K |
| Total profit | -26.13%706.95M | -37.74%459.67M | -47.47%200.49M | -124.87%-294.76M | -8.85%957.05M | 3.20%738.35M | -2.08%381.67M | -1.53%1.19B | 7.65%1.05B | 12.00%715.42M |
| Less:Income tax cost | -14.06%101.17M | -51.99%54.65M | -52.77%23.31M | -206.54%-105.31M | -18.91%117.72M | 11.66%113.83M | -16.71%49.34M | -29.31%98.85M | 11.66%145.17M | 20.94%101.95M |
| Net profit | -27.83%605.78M | -35.15%405.01M | -46.68%177.19M | -117.44%-189.45M | -7.24%839.33M | 1.80%624.51M | 0.55%332.33M | 2.12%1.09B | 7.03%904.85M | 10.65%613.47M |
| Net profit from continuing operation | -27.83%605.78M | -35.15%405.01M | -46.68%177.19M | -117.44%-189.45M | -7.24%839.33M | 1.80%624.51M | 0.55%332.33M | 2.12%1.09B | 7.03%904.85M | 10.65%613.47M |
| Less:Minority Profit | -139.09%-8.85K | -119.85%-2.84K | -228.86%-3.38K | 99.98%-761.46 | 101.03%22.63K | 102.53%14.31K | -99.40%2.63K | -193.33%-4.31M | -402.61%-2.2M | 47.57%-565.06K |
| Net profit of parent company owners | -27.82%605.78M | -35.15%405.02M | -46.68%177.19M | -117.37%-189.45M | -7.47%839.31M | 1.70%624.5M | 0.68%332.33M | 2.98%1.09B | 7.38%907.05M | 10.53%614.04M |
| Earning per share | ||||||||||
| Basic earning per share | -28.85%0.37 | -35.90%0.25 | -47.62%0.11 | -117.91%-0.12 | -7.14%0.52 | 2.63%0.39 | 0.00%0.21 | 0.00%0.67 | 5.66%0.56 | -17.39%0.38 |
| Diluted earning per share | -28.85%0.37 | -34.21%0.25 | -45.00%0.11 | -117.91%-0.12 | -7.14%0.52 | 0.00%0.38 | -4.76%0.2 | -1.47%0.67 | 7.69%0.56 | -17.39%0.38 |
| Other composite income | 56.71%7.31M | -53.95%2.43M | 98.25%-22.64K | 358.98%3.22M | 350.47%4.66M | 323.50%5.27M | -116.76%-1.3M | -113.64%-1.24M | 187.31%1.03M | -21.04%-2.36M |
| Other composite income of parent company owners | 56.91%7.31M | -53.91%2.43M | 98.26%-22.51K | 162.06%3.22M | 213.78%4.66M | 174.80%5.26M | -484.75%-1.29M | -147.05%-5.19M | -491.57%-4.09M | -522.96%-7.04M |
| Other composite income of minority owners | -131.25%-1.54K | -86.77%789.69 | 93.39%-128.23 | -99.93%2.6K | -99.90%4.94K | -99.87%5.97K | 99.48%-1.94K | 306.72%3.95M | 1,139.20%5.13M | 671.82%4.68M |
| Total composite income | -27.36%613.08M | -35.30%407.44M | -46.48%177.16M | -117.16%-186.22M | -6.83%843.99M | 3.05%629.78M | 0.33%331.03M | 1.14%1.09B | 7.30%905.88M | 10.61%611.11M |
| Total composite income of parent company owners | -27.36%613.09M | -35.30%407.44M | -46.48%177.17M | -117.15%-186.22M | -6.53%843.96M | 3.75%629.76M | 0.35%331.03M | 1.43%1.09B | 6.98%902.95M | 9.49%607M |
| Total composite income of minority owners | -137.68%-10.39K | -110.11%-2.05K | -611.47%-3.51K | 100.50%1.84K | -99.06%27.57K | -99.51%20.28K | -98.86%686.8 | -113.57%-368.22K | 1,149.92%2.93M | 316.95%4.11M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Zhongtianyun Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
